SHENZHEN, China, Jan. 19, 2012 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will participate in the Arab Health 2012 to be held between January 23 and 26 in Dubai, United Arab Emirates.
Arab Health is the most important annual medical exhibition in the Middle East. Last year, the event attracted more than 3,000 exhibitors and over 70,000 visitors from more than 60 countries. This year, Mindray will exhibit more than 50 devices, including six products that were newly launched in 2011, from its three core product segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. The six new products are:
- The DC-8 color ultrasound system
- The DP-50 black-and-white ultrasound product
- The DP-10 black-and-white ultrasound product
- The new iMEC series patient monitoring system
- The new iPM series patient monitoring system
- The urinary sediment analysis system from Hyssen, which was acquired by Mindray last year
Mindray’s Vice Presidents of International Sales and Marketing, Ms. Sarah Li and Mr. Richard Yang, will be attending the conference.
“We are delighted to showcase our latest products and other promising ones in the pipeline at this important international exhibition,” commented Ms. Li. “These products demonstrate the success of Mindray’s research efforts and our commitment to deliver high price-to-performance ratio products to the markets worldwide.”
The company will host booths S2E50 and MB10 at the Dubai International Convention & Exhibition Centre.
About Mindray
We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems. For more information, please visit http://ir.mindray.com.
For investor and media inquiries please contact:
In the U.S.:
Hoki Luk
Western Bridge, LLC
Tel: +1-646-808-9150
Email: hoki.luk@westernbridgegroup.com
In China:
Cathy Gao
Mindray Medical International Limited
Tel: +86-755-8188-8023
Email: cathy.gao@mindray.com
SOURCE Mindray Medical International Limited
